Japan Reports Modest, But Positive Effect Of Generic-Drug Emphasis
This article was originally published in PharmAsia News
In Japan, where an emphasis on buying generic drugs began in April 2008, the class of medicine comprised 7.2 percent of spending on prescription drugs. The increase, however, was only a 0.4 percent increase of 2007, the Ministry of Health, Labor and Welfare said. The ministry said the figures indicate the proportion of generics usage is still low, but that at least the change in policy has had an effect. Generics use amounted to 21.1 percent of drugs dispensed for treating blood and other bodily fluid problems in hospital settings. (Click here for more - a subscription may be required
You may also be interested in...
The Italian firm's move to license Isturisa from Novartis last year is paying dividends already and Recordati has already tripled its peak sales forecast for the Cushing's therapy.
Pfizer is up against AstraZeneca and Sanofi in developing competing approaches to tackling the unmet need in respiratory syncytial virus (RSV). But earlier failures mean all players will need much more data to sway regulators.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-two guidance documents have been posted on the tracker since its last update.